Dynamic changes in PSA levels predict prognostic outcomes in prostate cancer patients undergoing androgen -deprivation therapy: A multicenter retrospective analysis

BACKGROUND: Androgen-deprivation therapy (ADT) is used for the treatment of prostate cancer. However, the specific risk factors for the development of castration-resistant disease are still unclear. The present study sought to identify predictors of patient prognostic outcomes through analyses of cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Mingqiu, Mao, Yifeng, Guan, Chao, Tang, Zhizhong, Bao, Zhihang, Li, Yingbang, Liang, Guowu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948006/
https://www.ncbi.nlm.nih.gov/pubmed/36845723
http://dx.doi.org/10.3389/fonc.2023.1047388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948006/
https://www.ncbi.nlm.nih.gov/pubmed/36845723
http://dx.doi.org/10.3389/fonc.2023.1047388

Ejemplares similares